Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHill & Smith Regulatory News (HILS)

Share Price Information for Hill & Smith (HILS)

Share Price is delayed by 15 minutes
Get Live Data
2,865.00    0.00 (0.00%)
Bid:
2,855.00
Ask:
2,860.00
Spread: 5.00 (0.175%)
Market Cap: £2.24b
HILS Live PriceLast checked at - London Stock Exchange

Intraday Hill & Smith Share Chart

Director/PDMR Shareholding

19 Mar 2026 13:30

RNS Number : 3657X
Hill & Smith PLC
19 March 2026
 

19 March 2026

Hill & Smith PLC ('Hill & Smith' or the 'Company')Director and PDMR Shareholdings

Hill & Smith announces the following dealings by Directors and PDMRs of the Company in connection with its employee share plan arrangements.

Hill & Smith 2023 Long Term Incentive Plan - 2026 Award ('LTIP')

On 18 March 2026 (the 'Grant Date'), the Company granted awards under the Hill & Smith 2023 Long Term Incentive Plan to the Directors / PDMRs as set out below:

Director / PDMR

Name

Job Title

Type of award

Number of shares

Director

Rutger Helbing

Chief Executive Officer

Nil-cost option

57,935

Director

Chris McLeish

Chief Financial Officer

Nil-cost option

32,717

PDMR

Tim Tehan

Group President

Conditional award

20,053

PDMR

Nick Adcock

Group President

Nil-cost option

13,482

 

The number of shares over which the awards were granted was calculated based on a share price of £21.25, that being the closing mid-market price from the day immediately preceding the date of grant.

The Awards will vest based on the achievement of relative Total Shareholder Return (40%), Underlying EPS Growth (50%) and the Company's reduction in greenhouse gas emissions (10%) over a 3-year performance period. The detailed performance conditions will be provided in the 2026 Directors' Remuneration Report.

The Awards will (subject to the achievement of the performance conditions) vest following the end of the performance period, for Rutger Helbing and Chris McLeish the LTIP may not ordinarily be exercised until the end of a further two-year holding period.

Deferred Bonus Plan awards in respect of 2025 bonuses

On 18 March 2026 the Company granted awards under the rules of its Deferred Bonus Plan in respect of bonuses earned for the year ended 31 December 2025. The Company confirms that:

Director / PDMR

Name

Job Title

Type of award

Number of shares

Director

Rutger Helbing

Chief Executive Officer

Nil-cost option

19,365

Director

Chris McLeish

Chief Executive Officer

Nil-cost option

2,378

PDMR

Tim Tehan

Group President

Conditional award

3,335

PDMR

Nick Adcock

Group President

Nil-cost option

1,596

 

The awards will vest following the end of a two-year deferral period.

The Notification of Dealing Forms for the above transactions are set out below:

Notification of Dealing Form for Rutger Helbing

1.

Details of the person discharging managerial responsibilities/person closely associated

(a)

Name

Rutger Helbing

2.

Reason for the notification

(a)

Position/status

Chief Executive Officer

(b)

Initial notification/ Amendment

Initial notification

3.

Details of the issuer

(a)

Name

Hill & Smith PLC

(b)

LEI

2138003A3ISGQZBOWI83

4.1

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial Instrument

Ordinary shares of £0.25 each

(b)

Identification code of the Financial Instrument

GB0004270301

(c)

Nature of the transaction

Grant of nil-cost options under the Hill & Smith 2023 Long Term Incentive Plan

(d)

Price(s) and volume(s)

Price(s)

Volume

Nil

57,935

(e)

Aggregated information:

- Aggregated volume

- Price

N/A

(f)

Date of the transaction

18 March 2026

(g)

Place of the transaction

Outside a trading venue

4.2

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial Instrument

Ordinary shares of £0.25 each

(b)

Identification code of the Financial Instrument

GB0004270301

(c)

Nature of the transaction

Grant of nil-cost option under the Hill & Smith Deferred Bonus Plan

 

(d)

Price(s) and volume(s)

Price(s)

Volume

Nil

19,365

(e)

Aggregated information:

- Aggregated volume

- Price

N/A

(f)

Date of the transaction

18 March 2026

(g)

Place of the transaction

Outside a trading venue

 

Notification of Dealing Form for Chris McLeish

1.

Details of the person discharging managerial responsibilities/person closely associated

(a)

Name

Chris McLeish

2.

Reason for the notification

(a)

Position/status

Chief Financial Officer

(b)

Initial notification/ Amendment

Initial notification

3.

Details of the issuer

(a)

Name

Hill & Smith PLC

(b)

LEI

2138003A3ISGQZBOWI83

4.1

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial Instrument

Ordinary shares of £0.25 each

(b)

Identification code of the Financial Instrument

GB0004270301

(c)

Nature of the transaction

Grant of nil-cost options under the Hill & Smith 2023 Long Term Incentive Plan

(d)

Price(s) and volume(s)

Price(s)

Volume

Nil

32,717

(e)

Aggregated information:

- Aggregated volume

- Price

N/A

(f)

Date of the transaction

18 March 2026

(g)

Place of the transaction

Outside a trading venue

4.2

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial Instrument

Ordinary shares of £0.25 each

(b)

Identification code of the Financial Instrument

GB0004270301

(c)

Nature of the transaction

Grant of nil-cost options under the Hill & Smith Deferred Bonus Plan

 

(d)

Price(s) and volume(s)

Price(s)

Volume

Nil

2,378

(e)

Aggregated information:

- Aggregated volume

- Price

N/A

(f)

Date of the transaction

18 March 2026

(g)

Place of the transaction

Outside a trading venue

 

Notification of Dealing Form for Tim Tehan

1.

Details of the person discharging managerial responsibilities/person closely associated

(a)

Name

Tim Tehan

2.

Reason for the notification

(a)

Position/status

Group President

(b)

Initial notification/ Amendment

Initial notification

3.

Details of the issuer

(a)

Name

Hill & Smith PLC

(b)

LEI

2138003A3ISGQZBOWI83

4.1

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial Instrument

Ordinary shares of £0.25 each

(b)

Identification code of the Financial Instrument

GB0004270301

(c)

Nature of the transaction

Grant of a Conditional Award under the Hill & Smith 2023 Long Term Incentive Plan

(d)

Price(s) and volume(s)

Price(s)

Volume

Nil

20,053

(e)

Aggregated information:

- Aggregated volume

- Price

N/A

(f)

Date of the transaction

18 March 2026

(g)

Place of the transaction

Outside a trading venue

4.2

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial Instrument

Ordinary shares of £0.25 each

(b)

Identification code of the Financial Instrument

GB0004270301

(c)

Nature of the transaction

Grant of a Conditional Award under the Hill & Smith Deferred Bonus Plan

 

(d)

Price(s) and volume(s)

Price(s)

Volume

Nil

3,335

(e)

Aggregated information:

- Aggregated volume

- Price

N/A

(f)

Date of the transaction

18 March 2026

(g)

Place of the transaction

Outside a trading venue

 

 

Notification of Dealing Form for Nicholas Adcock

1.

Details of the person discharging managerial responsibilities/person closely associated

(a)

Name

Nick Adcock

2.

Reason for the notification

(a)

Position/status

Group President

(b)

Initial notification/ Amendment

Initial notification

3.

Details of the issuer

(a)

Name

Hill & Smith PLC

(b)

LEI

2138003A3ISGQZBOWI83

4.1

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial Instrument

Ordinary shares of £0.25 each

(b)

Identification code of the Financial Instrument

GB0004270301

(c)

Nature of the transaction

Grant of nil-cost options under the Hill & Smith 2023 Long Term Incentive Plan

(d)

Price(s) and volume(s)

Price(s)

Volume

Nil

13,482

(e)

Aggregated information:

- Aggregated volume

- Price

N/A

(f)

Date of the transaction

18 March 2026

(g)

Place of the transaction

Outside a trading venue

4.2

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial Instrument

Ordinary shares of £0.25 each

(b)

Identification code of the Financial Instrument

GB0004270301

(c)

Nature of the transaction

Grant of nil-cost options under the Hill & Smith Deferred Bonus Plan

 

(d)

Price(s) and volume(s)

Price(s)

Volume

Nil

1,596

(e)

Aggregated information:

- Aggregated volume

- Price

N/A

(f)

Date of the transaction

18 March 2026

(g)

Place of the transaction

Outside a trading venue

 

Enquiries:

Karen Atterbury

Company Secretary

0121 704 7430

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHAKCBDNBKDBND
Date   Source Headline
17th Jan 20171:16 pmRNSBlock Listing Six Monthly Return
16th Jan 20174:31 pmRNSDirector/PDMR Shareholding
19th Dec 20163:44 pmRNSDirector/PDMR Shareholding
14th Dec 20161:36 pmRNSTransaction in Own Shares
17th Nov 20167:00 amRNSChange in Board Responsibilities
17th Nov 20167:00 amRNSTrading Update
4th Nov 201610:45 amRNSHolding(s) in Company
1st Nov 20162:56 pmRNSTotal Voting Rights
7th Oct 201612:04 pmRNSTotal Voting Rights
12th Aug 20165:07 pmRNSDirector/PDMR Shareholding
5th Aug 20164:09 pmRNSHolding(s) in Company
4th Aug 20169:43 amRNSDirector/PDMR Shareholding
4th Aug 20167:00 amRNSHalf Year Results
4th Aug 20167:00 amRNSAcquisition
27th Jul 20163:00 pmRNSHolding(s) in Company
18th Jul 201611:53 amRNSBlock listing Interim Review
14th Jul 20167:00 amRNSAcquisition
5th Jul 20164:24 pmRNSHolding(s) in Company
5th Jul 20164:19 pmRNSHolding(s) in Company
17th Jun 201612:49 pmRNSNotice of Results
1st Jun 20162:33 pmRNSTotal Voting Rights
27th May 20162:16 pmRNSTransaction in Own Shares
26th May 20167:00 amRNSDirectorate Change
26th May 20167:00 amRNSBoard Appointment
20th May 20164:07 pmRNSDirector/PDMR Shareholding
17th May 20164:50 pmRNSNotification of Non-Executive Director Changes
17th May 20162:31 pmRNSResult of AGM
17th May 20167:00 amRNSAGM Trading Update
5th May 20169:26 amRNSTotal Voting Rights
15th Apr 20169:11 amRNS2015 Annual Report and Notice of 2016 AGM
5th Apr 201610:27 amRNSTotal Voting Rights
30th Mar 201610:34 amRNSDirector/PDMR Shareholding
24th Mar 20163:36 pmRNSDirector/PDMR Shareholding
18th Mar 20164:05 pmRNSDirector/PDMR Shareholding
9th Mar 20164:37 pmRNSTransaction in Own Shares
9th Mar 201610:57 amRNSTotal Voting Rights
9th Mar 201610:53 amRNSDisclosure of Home Member State
9th Mar 20167:00 amRNSFinal Results
24th Feb 20162:58 pmRNSDirector Declaration
23rd Feb 20163:02 pmRNSHolding(s) in Company
17th Feb 20164:25 pmRNSHolding(s) in Company
1st Feb 201611:55 amRNSTotal Voting Rights
27th Jan 20164:45 pmRNSBlocklisting Interim Review
22nd Jan 201612:12 pmRNSNotice of Preliminary Results
18th Jan 20164:18 pmRNSAdditional Listing
8th Jan 20165:10 pmRNSDirector/PDMR Shareholding
6th Jan 201610:21 amRNSTotal Voting Rights
1st Dec 201510:52 amRNSTotal Voting Rights
30th Nov 201512:05 pmRNSHolding(s) in Company
26th Nov 20157:00 amRNSAcquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.